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1. Introduction 
Obesity is closely linked to a variety of metabolic disorders, including insulin resistance, 
atherosclerosis and type 2 diabetes (Eriksson, 2007). Recent studies have indicated that 
adipose tissue is not only an energy store but also produces and secretes various bioactive 
molecules called adipocytokines, such as adiponectin, tumor necrosis factor-α (TNF-α), 
plasminogen activator inhibitor type 1 (PAI-1) and monocyte chemoattractant protein-1 
(MCP-1) (Hotamisligil & Spiegelman, 1994; Shimomura et al., 1996; Berg et al., 2002; Havel, 
2004). TNF-α is a major inflammatory adipocytokine that decreases the phosphorylation of 
insulin receptor substrate-1 (IRS-1), and this event leads to insulin resistance (Hotamisligil et 
al., 1993). Moreover, because it is well recognized that TNF-α increases the adhesion 
molecules such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion 
molecule-1 (ICAM-1) and MCP-1, all of which are key mediators involved in atherogenesis, 
over secretion of TNF-α may induce and accelerate atherosclerosis. On the other hand, 
adiponectin is a major anti-inflammatory adipocytokine that plays a pivotal role in the 
improvement of glucose and lipid metabolism and the prevention of atherosclerosis  
and inflammation (Yamauchi et al., 2002). Further, it has been clarified that adiponectin not 
only increases insulin sensitivity, but also has anti-atherosclerosis properties which decrease 
the expression of VCAM-1 and ICAM-1 (Ouchi et al., 1999) and suppresses the proliferation 
of vascular smooth muscle cells (Arita et al., 2002). In patients with insulin resistance, 
obesity or type 2 diabetes, serum adiponectin levels are reduced (Arita et al., 1999; Hotta  
et al., 2000). Further, previous studies showed that TNF-α and intracellular reactive oxygen 
species (ROS) decrease adiponectin expression (Kim et al., 2005; Soares et al., 2005; Simons  
et al., 2007). On the other hand, increases in adiponectin expression have been reported 
during adipocyte differentiation and transcriptional factors associated with adipogenesis, 
including CCAAT/enhancer-binding protein-α (C/EBP-α) and peroxisome proliferator-
activated receptor-γ (PPAR-γ), have been shown to up-regulate adiponectin expression 
(Adachi et al., 2009). 
Adipose tissue has been found to suffer chronic hypoxia during the development of obesity 
(Brook et al., 1972; Helmlinger et al., 1997), and these conditions may lead to metabolic 
disorders. Hypoxic conditions can be induced by the addition of certain chemicals called 
‘hypoxia mimetics’, such as the carcinogenic transition metal cobalt (Vincent et al., 1996). It 
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has been suggested that cobalt stabilizes transcriptional factor, hypoxia-inducible factor-1α 
(HIF-1α), from proteasomal degradation by inhibiting the activity of prolyl hydroxylases 
(PHDs) through Fe2+ substitution (Schofield & Ratcliffe, 2004). In these hypoxic conditions, it 
has been recognized that accumulated HIF-1α increases a wide variety of genes including 
vascular endothelial growth factor (VEGF), heme oxygenase-1 (HO-1), erythropoietin (EPO) 
and cytochrome p450 (CYP) 3A6 to ensure adaptation to low-oxygen tension (Levy et al., 
1995; Lee et al., 1997). On the other hand, the expression of CYP1A2, 2B and 2C are 
decreased by the activation of HIF-1α (Olsvik et al., 2006; Fradette et al., 2007). Further, it 
has been reported that both hypoxia and hypoxia mimetics increase ROS generation and 
dysregulate adipocytokines, and these conditions lead to and/or promote metabolic 
disorders (Schuster et al., 1989; Hosogai et al., 2007). 
To protect cells from oxidative stress, mammalian have anti-oxidative enzymes such as 
superoxide dismutase (SOD), catalase and glutathione peroxidase (Amstad & Cerutti, 1990; 
Cerutti et al., 1994). SOD is a major antioxidant enzyme that protects cells from the 
damaging effects of superoxide by accelerating the dismutation reaction of superoxide by 
approximately 10,000 times (Faraci, 2003). As shown in Table 1, there are three SOD 
isozymes in mammals; copper and zinc-containing SOD (Cu,Zn-SOD), manganese-
containing SOD (Mn-SOD) and extracellular-SOD (EC-SOD) (McCord & Fridovich, 1969; 
Keele et al., 1970; Marklund, 1982; Faraci, 2003). Among of three SOD isozymes, EC-SOD is 
secretory, tetrameric glycoprotein, whereas Cu,Zn-SOD and Mn-SOD are intracellular 
enzymes found predominantly in the cytoplasm and mitochondria, respectively. EC-SOD is 
a major SOD isozyme in the extracellular space but is distributed mainly in blood vessel 
walls (Ookawara et al., 1998). After secretion, EC-SOD slowly diffuses and binds to the 
heparan sulfate proteoglycans in the glycocalyx on the surface of most cell types in the 
vascular wall. The EC-SOD content is very low in the liver, heart, brain and other organs, 
with the exception of the lung, thyroid gland, and adipose tissue (Marklund, 1984). It was 
found that the plasma EC-SOD levels in type 2 diabetic patients were significantly and 
inversely related to the body mass index, homeostasis model assessment-insulin resistance 
index, but positively related to adiponectin levels (Adachi et al., 2004). Recently, we 
reported that cobalt chloride (CoCl2) decreases EC-SOD in green monkey kidney COS7 cells 
via intracellular ROS generation and p38-MAPK, a mitogen-activated protein kinase  
Molecular mass
Subunit
Metal (atom/subunit)
Location
Rate constant (M−1s −1)
Affinity for heparin
Carbohydrate
Cu,Zn-SOD
32,000
a2
1Cu, 1Zn
cytoplasm
 2 × 109
Mn-SOD
85,000
a4
1Mn
mitochondria
1.25 × 109
EC-SOD
1.25 × 109
135,000
a4
1Cu, 1Zn
extracell
 
Table 1. The properties of SOD isozymes 
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(MAPK), signaling cascade (Kamiya et al., 2008); however, the mechanisms of EC-SOD and 
adiponectin reductions during hypoxia remain unclear. Because the EC-SOD content in 
adipose tissue is comparably high, it is important to elucidate the regulation of EC-SOD may 
contribute to the control of cytotoxicity induced by intracellular ROS during hypoxia. 
In order to address these issues, we studied the regulation of EC-SOD expression by CoCl2 
and examined the role of ROS, inflammatory cytokine such as TNF-α and MAPK signaling 
cascades in these processes. Moreover, we also studied the regulation of adiponectin 
expression by CoCl2, because we hypothesized that the expression of EC-SOD might be co-
regulated with adiponectin in 3T3-L1 cells treated with CoCl2, leading to aggravate 
metabolic disorders.  
2. Methods 
2.1 3T3-L1 cell culture 
3T3-L1 mouse pre-adipocytes culture and their differentiation into adipocytes were 
carried out as described in previous report (Adachi et al., 2009). Briefly, pre-adipocytes 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 
10% foetal calf serum (FCS) until 2 days after confluence; then, their differentiation into 
adipocytes was induced by treating cells for 2 days with 5 µg/mL insulin, 0.5 µM 
dexamethasone and 0.5 mM isobutylmethyl-xanthine in DMEM, and then for 2 days with 
insulin (5 µg/mL) in the same medium. The cells were returned to the basal medium, 
which was replaced every other day. The effects of CoCl2 and hypoxia on gene expression 
were investigated using 8-day differentiated adipocytes. The induction of hypoxia (1% O2) 
was carried out in a culture chamber which controls O2 concentrations by supplying N2 
gas together with 5% CO2. After the cells were treated with CoCl2 or incubated with 
hypoxia (1% O2) for 24 h, RT-PCR and measurement of intracellular ROS generation were 
carried out. 
2.2 Oil red O staining 
Differentiation of 3T3-L1 mouse pre-adipocytes into mature adipocytes was confirmed by 
Oil red O staining as described previously (Sakaue et al., 2002). Briefly, the cells were 
washed twice with ice-cold PBS, and then the cells were fixed with 10% paraformaldehyde 
for 10 min at room temperature. After fixation, the cells were washed twice with ice-cold 
PBS and incubated with 60% isopropanol for 1 min followed by incubation with 1.8 mg/mL 
Oil red O solution for 20 min at room temperature. After the cells were washed twice with 
ice-cold PBS, Oil red O staining was monitored by microscope. 
2.3 Measurement of cellular protein 
We measured the cellular protein as an index of cell injury. After 3T3-L1 adipocytes were 
treated, the medium was aspirated and the cells were washed twice with ice-cold PBS and 
then scraped in 1 mL PBS. The cell suspension was homogenized using an ultrasonic 
homogenizer. The total protein in the supernatant was assayed using a Bio-Rad protein 
assay reagent (Bio-Rad Lab., CA, USA). 
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2.4 Reverse transcriptional polymerase chain reaction (RT-PCR) 
After 3T3-L1 adipocytes were treated, the medium was aspirated and the cells were washed 
twice with ice-cold PBS. The cells were lysed in 1 mL TRIzol reagent (Invitrogen, CA, 
USA). cDNA was prepared and RT-PCR performed using the methods described in our 
previous report (Adachi et al., 2009), with minor modifications. Densitometric analysis of 
the PCR products was performed with Multi Gauge V3.0 (Fuji Film, Japan).  
2.5 Measurement of intracellular ROS 
After the adipocytes were treated, the medium was aspirated and the cells were washed 
twice with PBS and incubated with fresh culture medium without serum containing 3 µM 5-
(and-6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) for 20 min 
at 37°C in 5% CO2/95% air. The cells were then washed twice with ice-cold PBS and then 
scraped in 1 mL PBS and centrifuged at 2,300 × g for 5 min at 4°C. The pellet was 
homogenized with 1 mL PBS using ultrasonic homogenizer and centrifuged at 2,300 × g for 
10 min at 4°C. The DCF fluorescence of the supernatant was measured using a fluorometer 
(excitation at 493 nm and emission at 527 nm). Total protein concentrations were measured 
using a protein assay reagent. 
2.6 Western blotting 
Whole cell extracts were prepared in lysis buffer as described previously (Kamiya et al., 
2008). Extracts containing 20 µg protein were separated by SDS-PAGE on 12% (w/v) 
polyacrylamide gels followed by transferring electrophoretically onto PVDF membranes. 
Subsequently, the membranes were incubated with the respective specific primary 
antibodies (C/EBP homologous protein (CHOP) and Actin). The blots were incubated with 
biotin-conjugated goat anti-rabbit IgG (for CHOP) or -mouse IgG (for Actin) antibody 
followed by incubating with ABC reagents (Vector Laboratories, Inc., Burlingame, CA, 
USA). Finally, the bands were detected using SuperSignal West Pico (Thermo Scientific, 
Rockford, IL, USA), and imaged using an LAS-3000 UV mini (Fuji Film).  
2.7 Statistical analysis 
The data shown are the mean ± SD of three separate experiments. Statistical significance was 
estimated using ANOVA followed by post hoc Bonferroni tests. A P-value less than 0.05 was 
considered significant. 
3. Results 
3.1 Differentiation of 3T3-L1 mouse pre-adipocytes into mature adipocytes 
We first investigated the differentiation of 3T3-L1 pre-adipocytes into mature adipocytes 
using Oil red O staining. As shown in Fig. 1A, the staining was not observed in 0 day, but 
observed in 8 days differentiated cells. Further, we measured the expression of adiponectin 
as an index of differentiation by RT-PCR. The expression of adiponectin was not observed in 
0 day, but drastically increased in the 8 day differentiated-adipocytes (Fig. 1B). From these 
observations, we considered that the cells were differentiated into mature adipocytes, and 
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we therefore investigated the effect of CoCl2 on the expression of EC-SOD, other SOD 
isozymes, adiponectin and transcriptional factors. 
0 day 8 day
Adiponectin
0 day 8 day
β-actin
A B
 
Fig. 1. Differentiation of 3T3-L1 mouse pre-adipocytes into mature adipocytes. 3T3-L1 pre-
adipocytes were differentiated by the method described above. After 8 day differentiation, 
the differentiation degree was evaluated by Oil red O staining (A) and RT-PCR analysis (B). 
3.2 Effect of CoCl2 and hypoxia on the protein content 
In order to elucidate the cytotoxicity of CoCl2 and hypoxia (1% O2), we measured the 
protein content of 3T3-L1 adipocytes treated with 0.3 mM CoCl2 or incubated under hypoxia 
for the several hours. As shown in Fig. 2, the protein content was not affected by CoCl2 and 
so from this we determined the concentrations of CoCl2 (0 to 0.3 mM) to use in this study. 
Moreover, the protein content was not affected under hypoxic condition. 
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Fig. 2. Effect of CoCl2 and hypoxia on the protein content. 3T3-L1 adipocytes were treated 
with 0.3 mM CoCl2 (closed column) or incubated under hypoxia (1% O2: gray column) for 
the indicated hours. After the cells were treated, protein contents were measured by using a 
Bio-Rad protein assay reagent. 
3.3 Effect of CoCl2 on the expression of SODs, adiponectin and transcriptional factors 
We next investigated the effect of CoCl2 on the expression of SODs, adiponectin and 
transcriptional factors such as C/EBP-α and PPAR-γ by RT-PCR. As shown in Fig. 3, 4, 
treatment with CoCl2 decreased the expression of EC-SOD mRNA in a CoCl2 dose- (Fig. 3) 
and time-dependent manner (Fig. 4). On the other hand, the other SOD isozymes (Cu,Zn-
SOD and Mn-SOD) were not affected when the applied concentration of CoCl2 was 0.3 mM 
for 24 h. It has been reported that adiponectin is suppressed in mRNA and protein levels 
during hypoxia; however, the expression of adiponectin during hypoxia induced by CoCl2 
was not fully elucidated. Treatment with CoCl2 markedly suppressed the expression of 
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adiponectin in a CoCl2 dose- and time-dependent manner. Additionally, the expression of 
C/EBP-α and PPAR-γ, well recognized as master regulators of adipogenesis and 
adiponectin, was similar to that of EC-SOD and adiponectin.  
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Fig. 3. Dose-dependent effect of CoCl2 on the expression of SODs, adiponectin and 
transcriptional factors. 3T3-L1 adipocytes were treated with the indicated concentrations of 
CoCl2 for 24 h. After the cells were treated, RT-PCR was carried out and these data were 
normalized using β-actin levels. (* p<0.05, ** p<0.01 vs. vehicle). 
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Fig. 4. Time-dependent effect of CoCl2 on the expression of SODs, adiponectin and 
transcriptional factors. 3T3-L1 adipocytes were treated with 0.3 mM CoCl2 for the indicated 
hours. After the cells were treated, RT-PCR was carried out and these data were normalized 
using β-actin levels. (* p<0.05, ** p<0.01 vs. untreated cells). 
3.4 Effect of hypoxia on the expression of SODs, adiponectin and transcriptional 
factors 
We further investigated the effect of hypoxia (1% O2) on the expression of SODs, 
adiponectin and transcriptional factors. Hypoxia decreased the expression of EC-SOD, 
adiponectin and C/EBP-α similar to CoCl2 treatment (Fig. 5); however, Cu,Zn-SOD, Mn-
SOD and PPAR-γ were not changed during hypoxia. 
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Fig. 5. Effect of hypoxia on the expression of SODs, adiponectin and transcriptional factors. 
3T3-L1 adipocytes were incubated under normoxia (20% O2: open column) or hypoxia (1% 
O2: closed column) for 24 h. After the cells were treated, RT-PCR was carried out and these 
data were normalized using β-actin levels. (** p<0.01 vs. normoxia). 
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3.5 Involvement of ROS in CoCl2-induced reduction of EC-SOD and adiponectin 
We previously reported that intracellular ROS are generated under hypoxic conditions 
induced by CoCl2 and lead to decrease the expression of EC-SOD in COS7 cells (Kamiya et 
al., 2008). Moreover, it has been reported that the expression of adiponectin is also decreased 
by the accumulation of intracellular ROS in 3T3-L1 adipocytes (Soares et al., 2005). As 
described in the previous reports, it was speculated that the reduction of EC-SOD and 
adiponectin was regulated by intracellular ROS-derived signaling. We therefore 
investigated the involvement of intracellular ROS in these reductions in this study. 
Treatment with H2O2 decreased the expression of EC-SOD and adiponectin, and 
pretreatment with antioxidant, trolox, partially, but significantly suppressed these 
reductions (Fig. 6A). We further investigated that generation of intracellular ROS during 
CoCl2-treatment using carboxy-H2DCFDA. As shown in Fig. 6B and C, treatment with CoCl2 
significantly increased intracellular ROS generation in a time-dependent manner and 
pretreatment with trolox attenuated CoCl2-triggered ROS generation. However, 
surprisingly, pretreatment with trolox did not attenuate the reduction of EC-SOD and 
adiponectin (Fig. 6D), suggesting that the expression of EC-SOD and adiponectin were not 
regulated by intracellular ROS-derived signaling. 
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Fig. 6. Involvement of ROS in CoCl2-induced reduction of EC-SOD and adiponectin. (A) 
3T3-L1 adipocytes were pretreated without (−) or with (+) 0.2 mM trolox for 2 h, and then 
the cells were treated without (−) or with (+) 0.5 mM H2O2 for 24 h. (B) The cells were treated 
with 0.3 mM CoCl2 for the indicated hours. (C, D) The cells were pretreated without (−) or 
with (+) 0.2 mM trolox for 2 h, and then the cells were treated without (−) or with (+) 0.3 mM 
CoCl2 for 24 h. After the cells were treated, RT-PCR (A, D) and assay of intracellular ROS 
generation (B, C) were carried out. All RT-PCR data were normalized using β-actin levels. 
(** p<0.01 vs. vehicle (A, C and D) or untreated cells (B), ## p<0.01, N.S.: not significant vs. 
H2O2-treated cells (A) or CoCl2-treated cells (C, D)). 
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3.6 Involvement of TNF-α in CoCl2-induced reduction of EC-SOD and adiponectin 
It is well recognized that the inflammatory adipocytokines including TNF-α are increased 
during adipocytes hypertrophy and hypoxic conditions (Ye et al., 2007). Moreover, we 
previously reported that exposure to TNF-α decreased EC-SOD in several kinds of cells 
(Adachi et al., 2006, 2009) and adiponectin in 3T3-L1 adipocytes (Adachi et al., 2009). 
Accordingly, we next investigated the involvement of TNF-α in the reduction of EC-SOD 
and adiponectin by CoCl2. Treatment with CoCl2 increased the expression of TNF-α at the 
mRNA (Fig. 7A), and pretreatment with actinomycin D, an inhibitor of mRNA synthesis, 
blocked the CoCl2-triggered reduction of EC-SOD and adiponectin (Fig. 7B). Further, 
pretreatment with infliximab, a chimeric monoclonal antibody against TNF-α, partially, but 
significantly, suppressed the CoCl2-triggered reduction of these genes (Fig. 7C), indicating 
that TNF-α plays an important role in the CoCl2-induced suppression of EC-SOD and 
adiponectin. 
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Fig. 7. Involvement of TNF-α in CoCl2-induced reduction of EC-SOD and adiponectin. (A) 
3T3-L1 adipocytes were treated without (−) or with (+) 0.3 mM CoCl2 for 24 h. (B, C) The 
cells were pretreated without (−) or with (+) 1 µg/mL actinomycin D (ActD) for 1 h (B) or 10 
µg/mL infliximab for 1 h (C), and then the cells were treated without (−) or with (+) 0.3 mM 
CoCl2 for 24 h. After the cells were treated, RT-PCR was carried out. All RT-PCR data were 
normalized using β-actin levels. (* p<0.05, ** p<0.01 vs. vehicle, # p<0.05, ## p<0.01 vs. 
CoCl2-treated cells). 
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3.7 Involvement of MAPK in CoCl2-induced reduction of EC-SOD and adiponectin 
In mammalian, there are three types of MAPK, such as c-jun N-terminal kinase (JNK), p38-
MAPK and extracellular regulated kinase (ERK) (Kyriakis & Avruch, 2001, Pearson et al., 
2001), and play several physiological roles including cell proliferation, differentiation and 
death. Additionally, we and others reported that activation of MAPK plays important roles 
in the TNF-α-induced reduction of EC-SOD in vascular smooth muscle cells (VSMCs) and 
adiponectin in 3T3-L1 adipocytes (Adachi et al., 2006, Kim et al., 2005). We, therefore, 
investigated the effect of MAPK inhibitors, such as SP600125 (for JNK), SB203580 (for p38-
MAPK) and U0126 (for ERK) on the reduction of EC-SOD and adiponectin. Pretreatment 
with SP600125, SB203580 or U0126 did not affect the basal expression of EC-SOD and 
adiponectin (data not shown), and SP600125 significantly suppressed the CoCl2-triggered 
reduction of EC-SOD and adiponectin, but others had no effects (Fig. 8), indicating that the 
expression of EC-SOD and adiponectin are regulated by JNK signaling cascades. 
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Fig. 8. Involvement of MAPK in CoCl2-induced reduction of EC-SOD and adiponectin. 3T3-
L1 adipocytes were pretreated without (−) or with 50 µM SP600125 (SP), SB203580 (SB) or 
U0126 (U) for 30 min, and then the cells were treated without (−) or with (+) 0.3 mM CoCl2 
for 24 h. After the cells were treated, RT-PCR was carried out. All RT-PCR data were 
normalized using β-actin levels. (** p<0.01 vs. vehicle, # p<0.05, ## p<0.01, N.S.: not 
significant vs. CoCl2-treated cells). 
3.8 CoCl2 did not induce ER stress in 3T3-L1 adipocytes 
It is well recognized that hypoxia is associated with endoplasmic reticulum (ER) stress, 
which induces metabolic disorders (Ozcan et al., 2004). Because the inhibitory effect of 
infliximab and actinomycin D on the reduction of EC-SOD and adiponectin by CoCl2 was 
partial, it was speculated that the involvement of other mechanisms, such as ER stress. 
Therefore, we finally investigated the involvement of ER stress in the reduction of EC-SOD 
and adiponectin. Treatment with ER stress inducer, thapsigargin, significantly increased the 
expression of ER stress markers, glucose regulated-protein 78 kDa (GRP78) and CHOP; 
however, treatment with CoCl2 did not affect the expression of these genes (Fig. 9A, B), 
suggesting that CoCl2 decreased the expression of EC-SOD and adiponectin through ER 
stress-independent mechanisms. 
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Fig. 9. Effect of CoCl2 and thapsigargin on the expression of GRP78 and CHOP. (A) 3T3-L1 
adipocytes were treated with 0.3 mM CoCl2 or 1 µM thapsigargin (Tg) for 24 h. (B) The cells 
were treated with 0.3 mM CoCl2 (Co) or 1 µM Tg for the indicated hours. After treatment, 
RT-PCR (A) and western blotting (B) were carried out. RT-PCR data were normalized using 
β-actin levels. (** p<0.01 vs. vehicle). 
4. Discussion 
It is well known that obesity, especially visceral fat accumulation, is closely related to a 
variety of metabolic disorders, including insulin resistance, atherosclerosis and type 2 
diabetes (Fox et al., 2007). Further, it has been shown that inflammatory adipocytokines, 
such as TNF-α, interleukin (IL)-1 and IL-6, are increased, while anti-inflammatory 
adipocytokines, such as adiponectin, are decreased during adipocyte hypertrophy (Ye et al., 
2007), all of which might lead metabolic disorder exacerbation. Additionally, it has been 
reported that adipose tissue suffers chronic hypoxia during above process (Brook et al., 
1972; Helmlinger et al., 1997), and lead to disturb adipose homeostasis by excessive 
production of ROS and TNF-α, or decrease of adiponectin. In this study, chemical hypoxia 
mimetic, CoCl2, decreased the expression of adiponectin and adipogenic master regulators, 
including C/EBP-α and PPAR-γ, in a CoCl2 dose- and time-dependent manner (Fig. 3, 4), 
and these observations were similar to hypoxia (1% O2 incubation), except for PPAR-γ (Fig. 
5). From these observations and previous reports, we speculated that hypoxia mimetic 
decreases adiponectin via C/EBP-α and/or PPAR-γ signaling cascades, similar to hypoxia. 
On the other hand, it has been well known that both hypoxia and hypoxia mimetics increase 
intracellular ROS generation through mitochondria-dependent and –independent 
mechanisms, respectively (Agani et al., 2000, Chandel et al., 1998). Similar to previous 
reports, we confirmed the intracellular ROS accumulation during CoCl2 treatment (Fig. 6B), 
suggesting that hypoxic adipocytes suffered from oxidative stress. To protect cells from the 
damaging effect of ROS, mammalian have several kinds of anti-oxidative enzymes, such as 
SOD, catalase and glutathione peroxidase. EC-SOD is the major SOD isozyme in 
extracellular fluids and protects cells from superoxide. We previously reported that the 
expression level of EC-SOD through the differentiation of 3T3-L1 adipocytes changes in a 
similar manner to adiponectin, C/EBP-α and PPAR-γ, and down-regulation of these 
proteins might induce and/or promote the pathogenesis of metabolic syndrome and 
atherosclerosis. In fact, it was found that the plasma EC-SOD levels in type 2 diabetic 
patients were significantly and positively related to adiponectin levels (Adachi et al., 2004). 
Because, the EC-SOD content of adipose tissue was relative highly expressed compared to 
other organs, such as liver, heart and brain, it might be important to elucidate the regulation 
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mechanism of that gene during hypoxia for the control of metabolic disorders. Recently, we 
reported that CoCl2 decreases the expression of EC-SOD in COS7 cells via intracellular ROS 
generation. In this study, treatment with CoCl2 (Fig. 3, 4), hypoxia (Fig. 5) and H2O2 (Fig. 
6A) significantly decreased the expression of EC-SOD and adiponectin, but not of Cu,Zn-
SOD and Mn-SOD. However, interestingly, an antioxidant, trolox, did not affect the 
reduction of EC-SOD and adiponectin by CoCl2 in spite of suppressing the effect of H2O2 on 
these genes (Fig. 6A). From these observations, it is speculated that CoCl2 decreases EC-SOD 
and adiponectin by intracellular ROS-independent, but another mechanisms. 
So far, it has been reported that the expression of EC-SOD was regulated by several kinds of 
cytokines, such as TNF-α, transforming growth factor-β (TGF-β), IL-4 and interferon-γ (IFN-
γ) (Marklund, 1992, Strålin & Marklund, 2000). Among of them, it has been well recognized 
that TNF-α is one of the most important adipocytokines involved in metabolic disorders, 
including insulin resistance, atherosclerosis and type 2 diabetes by decreasing the 
phosphorylation of IRS-1 and inducing adhesion molecules, such as VCAM-1, ICAM-1 and 
MCP-1. Moreover, we and others showed that TNF-α decreases EC-SOD and adiponectin in 
VSMCs and 3T3-L1 cells, respectively (Adachi et al., 2006, Kim et al., 2005). Accordingly, we 
investigated the involvement of TNF-α in the reduction of EC-SOD and adiponectin by the 
addition of CoCl2. Treatment with CoCl2 significantly increased TNF-α expression (Fig. 7A), 
and infliximab partially, but significantly, attenuated the reduction of EC-SOD and 
adiponectin by CoCl2 (Fig. 7C). Additionally, an inhibitor of mRNA synthesis, actinomycin 
D, blocked the reduction of these expressions (Fig. 7B). These results suggested that CoCl2 
decreases EC-SOD and adiponectin via TNF-α; however, because the inhibition rate of EC-
SOD and adiponectin reductions by infliximab is partial, we speculated that the mechanisms 
of these reductions by CoCl2 involve other factors. Recently, it has been well known that 
hypoxia induces ER stress, which induces the apoptotic process (Kuznetsov et al., 1996). To 
assess the induction of ER stress by CoCl2, we measured the expression of ER stress marker, 
GRP78 and CHOP. Treatment with ER stress inducer, such as thapsigargin, drastically 
increased the expression of GRP78 and CHOP at mRNA and protein levels, but treatment 
with CoCl2 did not induce the ER stress (Fig. 9), suggesting that CoCl2 decreased the 
expression of EC-SOD and adiponectin through ER stress-independent mechanisms. 
We finally investigated the role of MAPK in the reduction of EC-SOD and adiponectin. 
There are three major subfamilies: JNK, p38-MAPK and ERK. Moreover, we previously 
reported that the expression of EC-SOD was regulated by p38-MAPK signaling cascades in 
CoCl2-treated COS7 cells (Kamiya et al., 2008). However, in this study, pretreatment with a 
JNK inhibitor, SP600125, suppressed the reduction of EC-SOD and adiponectin but others, 
SB203580 and U0126, did not affect these reductions, indicating that CoCl2 decreases EC-
SOD and adiponectin through JNK signaling cascades. In our previous report, we showed 
the involvement of ROS and p38-MAPK in the regulation of EC-SOD in COS7 cells (Kamiya 
et al., 2008); however, in this study, we did not observe the involvement of intracellular ROS 
and p38-MAPK in the reduction of EC-SOD by CoCl2. From these observations, we 
speculated that the difference of signal molecules leads the activation of different MAPK 
involved in the regulation of EC-SOD. It has been shown that the expression of mouse EC-
SOD is regulated by transcriptional factors such as Sp1, Sp3, Ets, Kruppel-like and myeloid 
zinc finger-1 those bind to the corresponding cis-element in the promoter region (Zelko et 
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al., 2003, 2004, 2008).  According to previous reports, we hypothesized that the regulation of 
EC-SOD might be also mediated by these transcriptional factors. 
5. Conclusion 
The EC-SOD content is very low compared to other SODs in parenchymal cells. However, 
because it is known that adipose tissue has a moderately high content of EC-SOD, EC-SOD 
might have an important protective role as an anti-inflammatory factor. In this study, we 
demonstrated that the expression of EC-SOD was co-regulated with adiponectin through 
TNF-α and JNK signaling cascades. From these observations, it is speculated that the 
reduction of EC-SOD by hypoxic conditions is similar to adiponectin and leads to a decrease 
in the resistance to oxidative stress. Overall, it is speculated that the reduction of EC-SOD 
leads to decreased resistance to oxidative stress and accelerates ROS-derived diseases, and 
prevents the reduction of EC-SOD, contributing to the control of redox homeostasis under 
hypoxic conditions.  
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